找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: New Drug Development; An Introduction to C J. Rick Turner Book 2010Latest edition Springer Science+Business Media, LLC 2010 Clinical.Develo

[复制链接]
楼主: microbe
发表于 2025-3-23 13:31:22 | 显示全部楼层
发表于 2025-3-23 15:11:59 | 显示全部楼层
introduction to statistics and illustrates its important rolNew Drug Development: Second Edition provides an overview of the design concepts and statistical practices involved in therapeutic drug development. This wide spectrum of activities begins with identifying a potentially useful drug candidat
发表于 2025-3-23 20:27:58 | 显示全部楼层
Book 2010Latest editionhis wide spectrum of activities begins with identifying a potentially useful drug candidate that can perhaps be used in the treatment or prevention of a condition of clinical concern, and ends with marketing approval being granted by one or more regulatory agencies. In between, it includes drug mole
发表于 2025-3-24 01:44:50 | 显示全部楼层
http://image.papertrans.cn/n/image/665160.jpg
发表于 2025-3-24 04:20:31 | 显示全部楼层
发表于 2025-3-24 09:44:42 | 显示全部楼层
Statistical Analysis,As noted in Chapter 1, Statistics can be thought of as an integrated discipline that includes several steps:
发表于 2025-3-24 12:14:50 | 显示全部楼层
发表于 2025-3-24 17:03:03 | 显示全部楼层
Nonclinical Research,egulatory governance, and reports of them are included in regulatory submissions requesting marketing approval. Three areas of investigation are considered here: pharmacokinetics, pharmacology, and toxicology. The scientific rationale of the studies is addressed, along with a summary of appropriate regulatory guidance.
发表于 2025-3-24 19:38:31 | 显示全部楼层
Designing Clinical Trials, design, conduct, and analysis impose artificial divisions on a process whose very nature is interactive and integrative. However, there is benefit in looking at components separately, since discussions can temporarily focus on one or two of them before illustrating the interrelatedness of all three. This chapter focuses on study design.
发表于 2025-3-25 01:08:39 | 显示全部楼层
Efficacy Assessment,g approval, that is, it needs to have a favorable benefit–risk profile. Therapeutic benefit, operationalized as efficacy, is evaluated in therapeutic exploratory and therapeutic confirmatory trials, trials in which the subjects have the disease or condition of biological concern.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 11:34
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表